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Abstract
Physical performance is determined both by biophysical and physiological limitations and behav-
ioral characteristic, specifically motivation. We applied an experimental evolution approach com-
bined with pharmacological manipulation to test the hypothesis that evolution of increased aerobic
exercise performance can be triggered by evolution of motivation to undertake physical activity.
We used a unique model system: bank voles from A lines, selected for high swim-induced aerobic
metabolism (VO2swim), which achieved a 61% higher mass-adjusted VO2swim than those from un-
selected C lines. Because the voles could float on the water surface with only a minimum activity,
the maximum rate of metabolism achieved in that test depended not only on their aerobic capacity,
but also on motivation to undertake intensive activity. Therefore, we hypothesized that signaling of
neurotransmitters putatively involved in regulating physical activity (dopamine and noradrenaline)
had changed in response to selection. We measured VO2swim after intraperitoneal injections of sa-
line or the norepinephrine and dopamine reuptake inhibitor bupropion (20 mg/kg or 30 mg/kg).
Additionally, we measured forced-exercise VO2 (VO2max). In C lines, VO2swim (mass-adjusted
mean 6 standard error (SE): 4.0 6 0.1 mLO2/min) was lower than VO2max (5.0 6 0.1 mLO2/min), but
in A lines VO2swim (6.0 6 0.1 mLO2/min) was as high as VO2max (6.0 6 0.1 mLO2/min). Thus, the
selection effectively changed both the physiological–physical performance limit and mechanisms
responsible for the willingness to undertake vigorous locomotor activity. Surprisingly, the drug
had no effect on the achieved level of VO2swim. Thus, the results did not allow firm conclusions
concerning involvement of these neurotransmitters in evolution of increased aerobic exercise per-
formance in the experimental evolution model system.
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The physiological basis of physical activity is central to both evolu-
tionary biology and medicine, as physical performance is closely
related to Darwinian fitness (Ekkekakis et al. 2005) and has tremen-
dous beneficial effects on many aspects of human health (Booth and
Lees 2007). The actual level of physical performance of an animal is
determined not only by biophysical and physiological limitations,
such as muscle strength or cardiovascular efficiency, but it is also
controlled by central nervous system (Knab and Lightfoot 2010;
Garland et al. 2011; Loprinzi et al. 2013). Despite intensive
research, it is uncertain which neurophysiological mechanism deter-
mines whether an animal will undertake physical effort and to what
physiological level the animal will use it physical abilities (Knab and
Lightfoot 2010; Garland et al. 2011; Rauch et al. 2013). Similarly,
it is unknown why some animals choose to perform at the upper
level of their physical abilities, whereas others prefer to exercise at
slower pace, far from their physiological limit (Swart et al. 2009).
The level of locomotor activity is associated with the rate of
aerobic metabolism. Aerobic capacity (the maximum forced-exercise
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rate of oxygen consumption: VO2max) is an important trait in evo-
lutionary-comparative physiology, because of its role in the evolu-
tion of locomotor performance. Moreover, it is widely recognized to
be involved in the evolution of endothermy and hence evolution of
avian and mammalian lineages, including humans (Garland and
Carter 1994; Koch and Britton 2008). VO2max is also considered
an important trait in medical physiology as an index of physical fit-
ness and human health (see Arena et al. 2010 for a review). Exercise
behavior and the maximum rate of aerobic metabolism are geneti-
cally correlated (Waters et al. 2008). Because the level of physical
performance is regulated by the central nervous system, we can ex-
pect similar influence of neuronal factors on the maximum aerobic
metabolism achieved during exercise. However, despite widespread
application of VO2max measurements, the influence of neurobio-
logical factors on the achieved VO2max value is often neglected
(Noakes 2008).
The central nervous system regulates all types of physical acti-
vity, e.g., spontaneous, voluntary, vigorous, and urgent motor be-
havior (Garland et al. 2011; Rauch et al. 2013). The system controls
each step of exercise performance: from decision to undertake acti-
vity and regulation of its intensity, to exercise termination.
Engagement in physical activity (e.g., endurance running) can have
beneficial effects on reproduction, survival and health, but it is also
energetically costly, time-consuming, and even risky (Ekkekakis
et al. 2005). It has been proposed that neurobiological rewards (e.g.,
pleasurable feeling of euphoria) could have evolved as a mechanism
motivating animals to engage in physical activity in order to, e.g.,
acquire food or avoid becoming food (Ekkekakis et al. 2005). A phe-
nomenon known as “runners’ high”, i.e., the pleasurable and re-
warding feeling connected with performing physical exercises, seems
to correspond to the evolutionary context (Dietrich and McDaniel
2004; Garland et al. 2011). Thus, it can be hypothesized that evolu-
tion of increased aerobic exercise performance can be triggered by
evolution of neurophysiological “motivation” to undertake physical
activity.
To test the above hypothesis we used a unique animal model—
bank voles (Myodes glareolus; Schreber, 1780) selected toward high
swim-induced aerobic metabolism (A lines). After 19 generations of
selection, animals from the A lines achieved a 61% higher mass-ad-
justed aerobic metabolism during swimming (VO2swim, Figure 1A,
B) than unselected, control lines (C lines). During selection trials,
the voles did not have to swim vigorously but could float on the
water surface using little energy. Thus, VO2swim is not the max-
imum rate of aerobic metabolism (i.e., the aerobic capacity) in the
strict sense used in exercise physiology (VO2max), but a measure of
voluntary maximum rate of oxygen consumption, which depends on
the behavioral characteristics such as motivation to work.
Importantly, in generation 6 of the experiment, when the difference
in VO2swim between the A-selected and C-control lines was about
23% (Figure 1A), VO2max measured as the maximum rate of oxy-
gen consumption during forced running on a treadmill was higher
than VO2swim both in the A (24%) and C lines (33%), yet VO2max
was more than 15% higher in A than in C lines (Sadowska 2008,
Koteja et al. 2009). Thus, the selection for the increased sub-
maximal (to some extent voluntarily achieved) aerobic performance
effectively changed both the physiological–physical performance
limit (VO2max, i.e., the aerobic capacity), and neurophysiological
mechanisms responsible for willingness of the voles to undertake
vigorous locomotor activity.
Neurotransmitters putatively involved in the regulation of phy-
sical activity motivation are, amongst others, dopamine and
noradrenaline (norepinephrine). Dopamine is implicated in motiva-
tion, rewarding, behavioral activation, motor movement, and physi-
cal activity (Vallone et al. 2000; Knab et al. 2009). In the central
nervous system, noradrenaline plays a role in the control of level of
arousal, reward mechanisms and consciousness (Roelands and
Meeusen 2010). Genetic or pharmacological modifications of dopa-
mine and noradrenaline neurotransmission result in changes of loco-
motor activity (Perona et al. 2008, Napolitano et al. 2010). Hence,
we could expect that increased performance of voles from A lines is
due to altered dopaminergic or noradrenergic signaling.
A change in particular neurotransmission can cause an altered
response to a pharmacological agent; therefore, pharmacological
manipulation is often used to investigate putative changes in neuro-
transmission (e.g., Rhodes et al. 2001, Keeney et al. 2008,
Napolitano et al. 2010). For example, psychostimulants such as am-
phetamine increase locomotor activity in wild-type rodents by
increasing the dopaminergic and noradrenergic signaling
(Napolitano et al. 2010). Simultaneously, the same stimulants de-
crease locomotor activity in hyperactive rodents in which the basal
level of dopamine is increased (Gainetdinov et al. 1999, Napolitano
et al. 2010). That well-documented, paradoxical calming effect of
stimulants is hypothesized to result from activation of inhibitory
autoreceptors in hyperdopaminergic animals (Solanto 1998,
Napolitano et al. 2010). In this study, we used pharmacological ma-
nipulation to investigate if the increased performance of bank voles
Figure 1. The direct effect of selection for high rate of swim-induced aerobic
metabolism (VO2swim) in bank vole. (A) Comparison of VO2swim in the C-
control and A-selected lines across 19 generations (replicate line means, not
adjusted for body mass; in generations 12 and 15–18 the selection was
relaxed); (B) the relationship between VO2swim and body mass in females
and males from the C and A lines in generation 19, from which individuals for
this research were sampled. The dotted vertical line indicates mean body
mass (23.7 g) used for calculating mass-adjusted VO2swim.
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from A lines is related to changes in the dopaminergic and noradre-
nergic signaling in the brains. We used bupropion, a dopamine and
noradrenaline reuptake inhibitor, that increases physical activity in
normal humans and rodents (Sidhpura et al. 2007; Mori et al. 2013)
and decrease activity in Attention deficit hyperactivity disorder pa-
tients (Biederman 2005) as well as hyperactive mice (Napolitano et al.
2010). Therefore, we expected that if the selection toward high rate of
aerobic metabolism resulted in changed dopamine and noradrenaline
signaling, bank voles from the A and C lines will respond differently
to the administration of bupropion. Specifically, bupropion injection
could increase VO2swim achieved by the voles from C lines and simul-
taneously decrease the activity of voles from A lines if the basal level
of dopamine and noradrenaline is increased in those animals.
Materials and Methods
We used bank voles from generation 19 of an artificial selection ex-
periment, in which 4 replicate lines of a nonlaboratory rodent are se-
lected for high rate of aerobic metabolism achieved during
swimming test (VO2swim; “A” —aerobic lines), and 4 replicate lines
are maintained as unselected control (“C” lines). The general object-
ives of the selection experiment, the rational of choosing the selec-
tion criterion, the breeding design, and the detailed history of
experiment are described in our previous reports (Konczal et al.
2015; Sadowska et al. 2008, 2015).
We measured VO2swim with 2, custom-built, open-flow respiro-
metric systems (Koteja 1996). In most instances, measurements were
conducted simultaneously in 2 animals. Details of the systems’ con-
struction changed across the course of the selection experiment. In
generation 19, we used FC-10 oxygen analyzer and CA2-2A carbon
dioxide analyzer in 1 system, and FC-10 a oxygen analyzer (without
carbon dioxide analyzer) in the second (Sable Systems, Las Vegas,
NV, United States). The 3-dm3 respirometric chamber (a cylindrical,
transparent glass jar, 15 cm diameter) was partly filled with water
(6-cm space between the water surface and the top of the chamber
was maintained), so the voles could swim freely. The nominal air
flow through respirometric chamber was 2000 mL/min, regulated
by a mass-flow controller (GFC17: Aalborg, Orangeburg, NY,
United States; or ERG3000: Beta-Erg, Warszawa, Poland). A sample
of excurrent air was dried first with either ND2 nafion tube or DG-
1 cold-trap (Sable Systems) and then with chemical absorber
(magnesium perchlorate), and directed to gas analyzers, which re-
corded the gas concentrations every second. The selection criterion
was 1-min VO2swim corrected for effective volume (calculated
according to appropriate equations in Koteja 1996). The water tem-
perature was 38C to ensure that the animals were using energy
only for locomotor activity and not for thermoregulation. We
added a drop of dog shampoo to the water to ensure soaking of the
entire fur.
In generation 19, we measured VO2swim of 371 females and
443 males from A lines and 116 females and 112 males from C lines
at the age of 80–85 days, as a part of our regular selection program.
Based on the results of these whole-generation measurements, called
later a “selection trial”, we chose 6 males and 6 females from each
of the A and C lines for further pharmacological experiment (96 ani-
mals in total). The sample could not include voles that achieved the
best results during the trial, as those animals were used for produc-
ing the next generation. Therefore, to avoid a bias, voles with the
lowest results, as well as those that could not swim or were diving,
were also excluded. Thus, the animals used in the pharmacological
experiment represented the medium values in the distribution of
VO2swim within a particular line. To maximize independence of the
observations (and simplify statistical models) we included only 1 in-
dividual from a full-sibling family. In each family, the single individ-
ual was sampled from 1 of 4 subsequent litters (1st to 4th) and that
grouping was included in statistical analyses. The descriptive statis-
tics concerning both the whole generation and the sample of animals
used in pharmacological trials are presented in Table 1.
The animals were kept in standard plastic mice cages with saw-
dust bedding, under long photoperiod (16:8 h light:dark; light phase
was starting at 2 AM) and temperature 20 6 1C. We kept 3 animals
in a cage, but 4 days before the pre-trial the animals were separated
to individual cages. Standard rodent food (Labofed H, Kcynia,
Poland) and water were available ad libitum.
All procedures associated with the breeding scheme, the selection
protocol as well as experimental procedures was approved by the
Local Bioethical Committee in Krakow, Poland (No. 68/2012 and
No. 61/2014).
Pharmacological experiment
About 15 weeks after the selection trial we started a series of 5
VO2swim trials on each individual, according to the following
schedule:
- pre-trial: after saline injection,
- 3 main pharmacological trials, in random order: after injection of
either saline or bupropion in 1 of 2 doses (low: 20 mg/kg, high:
30 mg/kg), and
- post-trial: after saline injection.
We maintained 1-week breaks between each trial to minimize a
carry-over effect. During the pre- and post-trials, performed to test
Table 1. Body mass (in grams) and the rate of swim-induced oxygen consumption (VO2swim [mLO2/min]) achieved by all bank voles from the
19th generation that underwent selection trial and the sub-sample of voles used in the pharmacological experiment: simple means 6 standard
deviations (SDs) and the least squares mean (LSM) of VO2swim ANCOVA-adjusted for mean body mass (23.7 g) 6 standard error (SE)





All animals generation 19th C Female 116 20.4 6 3.8 3.4 6 0.5 3.5 6 0.08
Male 112 24.2 6 4.2 3.7 6 0.5 3.6 6 0.07
A Female 371 22.5 6 2.9 5.7 6 0.6 5.8 6 0.06
Male 443 25.5 6 3.3 6.0 6 0.7 5.7 6 0.05
Animals used in
pharmacological experiment
C Female 24 20.1 6 3.8 3.4 6 0.3 3.4 6 0.07
Male 24 24.3 6 4.0 3.7 6 0.3 3.6 6 0.06
A Female 24 22.5 6 2.9 5.7 6 0.6 5.7 6 0.07
Male 24 25.4 6 4.1 6.0 6 0.7 5.6 6 0.07
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for putative effect of memory, training or age, we administered only
saline. All the injections were administered intraperitoneally (i.p.) in
volume of 10 mL/kg (i.e., about 0.2 mL per individual vole), 30 min
before the swimming test, i.e., around the expected time of peak
brain dopamine concentration (Sidhpura et al. 2007). All the meas-
urements were performed in 3 blocks, comprising 32 individuals
(2 individuals from each sex and replicate line) measured on the
same day. We applied the same procedures to all blocks during 3
consecutive measurement days. We prepared the fresh drug’s solu-
tions on each measurement day, an hour before the first injection.
After dissolving bupropion hydrochloride (Biokom, Janki, Poland)
in 0.9% saline, the solution was filtered with syringe filters with
micropores 0.2 mm (Rotilabo, Linegal Chemicals, Warsaw, Poland).
Forced running
Three weeks after the post-trial, we measured the maximum rate of
oxygen consumption achieved during forced running (VO2max) in a
motorized treadmill enclosed within a respirometric chamber (type
BTU-100-1U-M, Bio-Sys-Tech, Bialystok, Poland), according to a
generally applied protocol (e.g., Rezende et al. 2005; Arena et al.
2010). In previous experiments, we have already successfully
applied the protocol to our voles (Sadowska 2008). The tested vole
was placed in the chamber while the treadmill was stopped, and
after 1 min the treadmill was started at an initial speed of 6 m/min.
Subsequently the speed was increased every 45 s by 6 m/min. The
voles were forced to run by mild electric shocks (160 V, 0.5–1.5 mA)
provided through bars at the end of the moving belt. Before each
trial, we wetted the legs and abdomens of the voles in order to in-
crease electrical conductivity. Without this procedure some animals
lie on the bars and ignore the electric stimulation. We performed the
trial till exhaustion, thus we ended the trial when the vole failed to
keep pace with the treadmill. The measurement lasted for up to
15 min. Before the actual measurement, we performed 2 training tri-
als to familiarize the voles with the novel situation and let them
learn continuous running on the treadmill.
Statistical analysis
The main analyses were performed by means of nested analyses of
covariance (ANCOVA) mixed models, implemented in SAS version
9.3 (SAS Institute Inc., Cary, NC, USA) mixed procedure (with
REML estimation method). Body mass was analyzed with
ANCOVA including fixed effects of line Type (selected vs. control),
Sex, and line Type Sex interaction and random effects of replicate
Line (nested in line Type), Family nested in Line, and Line Sex
interaction. The models included also Litter Size, Number of the
Litter of the same female and type of Analyzer as cofactors. The rate
of swim-induced aerobic metabolism (VO2swim) during the selec-
tion trial was analyzed with ANCOVA including the same effects
listed above and Body Mass as covariate. We tested the significance
of random factors (replicate Lines, their interactions with other fac-
tors, Family) with likelihood ratio test (only if the variance estima-
tion was positive).
We performed repeated measures ANCOVAs to compare: 1)
pre- and post-trial VO2swim (training effect), 2) the pre-trial VO2
swim with VO2max (voluntary vs. forced performance), and 3) the
VO2swim achieved during 3 pharmacological trials (the focal ana-
lysis in this work: drug effect). These models included the same be-
tween-subject effects as in the model described above except Family,
because families were represented by only 1 individual. In the ana-
lysis of Exercise type, the effect of Analyzer was not included, either,
because all measurements of VO2max were performed on the same
analyzer. The within-subject (within-individual) fixed effects, appro-
priate for the particular model, were: 1) Trial (pre vs. post), 2)
Exercise type (swim vs. run), or 3) Drug (saline vs. bupropion low
dose vs. bupropion high dose). The models included also fixed inter-
action between line Type and the appropriate within-subject factor
(line TypeTrial, line TypeExercise type or line TypeDrug) as
well as a respective random interaction (LineTrial,
LineExercise type or LineDrug). In the analysis of the drug ef-
fect, we considered 2 models in which a repeated measure factor was
Drug or Number of a trial (the trial order). Based on Akaike informa-
tion criterion (AIC), we selected the model with Number of a trial as
a repeated measure factor. For all repeated measure models, we se-
lected the unstructured covariance structure as the most appropriate.
Preliminary models also included interactions between Sex and
other fixed effects. These interactions, however, were not of the
main interest from the perspective of the study, and—when nonsig-
nificant (P<0.05)—were excluded from the final analysis.
Preliminary ANCOVAs included also interactions between Body
Mass and the main categorical effects (tests of homogeneity of
slopes). We excluded these interactions from final models if they
were not significant. However, the slopes of the relationships be-
tween VO2 and Body Mass were always higher in A than in C lines,
and the difference was significant in most of the analyses. To investi-
gate whether the levels of VO2 differ between the line Types in the
range of observed body mass, we coded Body Mass by subtracting
from the actual body mass the mass of the lightest animal in the
dataset: 13 g in the analyses of VO2swim achieved during selection
trial, and 15 g in the other analyses. Because the slope of the relation
between VO2 and body mass was always steeper in A than in C
lines, demonstrating a significantly higher level of VO2 in A lines at
the minimal body mass implies that the difference is significant also
for the entire range of body mass. For a more transparent presenta-
tion of the results, we performed also the analyses for the mean
body masses (23.7 g in the analysis of the selection trial VO2swim,
and about 25 g in the other analyses).
We excluded statistical outliers from the analysis when the stu-
dentized residual was higher than 3.0. In that way, we excluded 2
outliers from the analysis of pre- and post-trial, 2 outliers from the
analysis of Exercise type effect, and 4 outliers from drug effect ana-
lysis. In the analysis of selection-trial VO2swim for all voles in gen-
eration 19, i.e., a much larger sample, we increased the threshold to
3.5 (3 outliers were excluded). In all models, we used the
Satterthwaite’s approximation to calculate the effective degrees of
freedom in the denominator of the F-test. Tukey–Kramer adjustment
was used for pairwise a posteriori comparisons.
Results
The effect of body mass
In the selection trial, body mass of bank voles ranged from 13 to
35 g (Figure 1B) and mean body mass was 23.7 g (Table 1). The
body mass did not differ between voles from A and C lines
(F1,6¼1.8, P¼0.230). Females were significantly lighter than males
(F1,366¼204, P<0.0001), but the line Type Sex interaction was
not significant (F1,362¼2.7, P¼0.102). The body mass was affected
by the Litter Number in which the animal was reared (LSM 6 SE:
1st litter 22 6 0.8, 2nd litter 23 6 0.7, 3rd and 4th litter combined
23 6 0.7; F2,997¼12.4, P<0.0001) and number of pups in the litter
(slope 6 SE: 0.3 6 0.06, t957¼4.2, P<0.0001). Similarly, in the
sample of 96 voles used later in pharmacological experiment there
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was no difference in body mass between line Types (F1,7¼0.6,
P¼0.477), females had lower body mass than males (F1,81¼24.3,
P<0.0001) and the interaction line Type Sex was not significant
(F1,81¼0.6, P¼0.449). Here the cofactors were not significant (the
Litter Number: F2,83¼2.7, P¼0.074, number of pups in a litter:
F1,85¼0.7, P¼0.787).
The rate of oxygen consumption measured either during all the
swimming trials (VO2swim) or the forced running trial (VO2max)
increased with body mass (P<0.0002), and the slope of the rela-
tionship was always higher in A than in C lines (positive Line
TypeBody mass interaction; Table 2, Figures 1B, 2A, B, 3A). At
the minimal observed body mass, voles from the A lines achieved
significantly higher VO2 than those from C lines (Table 2, Figures
1B, 2A, B, 3A). Therefore, because the difference always increased
with body mass (slopes higher in A than in C lines), we can infer
that the difference was significant for the whole range of voles’ body
mass. Unless otherwise stated, further results concern models for
mean body mass.
The direct effect of selection
In the selection trial, voles from the A lines achieved a significantly
higher mass-adjusted VO2swim than voles from C lines (adjusted
for a mean body mass of 23.7 g; F1,7.5¼827, P<0.0001, Figure 1B,
Table 1). Analyzing the effect of sex was complicated because the re-
gression slope was steeper for males than for females (SexBody
mass interaction: F1,953¼8.0, P¼0.005; Figure 1). At the minimal
observed body mass (13 g), females achieved a higher VO2swim
than males (F1,906¼8.0, P¼0.006), but the difference between
sexes decreased with body mass and in the middle of body mass
ranged it reversed, so that at the maximal observed body mass males
had higher VO2swim than females (F1,889¼6.0, P¼0.014). For the
VO2swim adjusted for a mean body mass, the effect of Sex was not
significant (F1,567¼0.04, P¼0.87), but line Type Sex interaction
was highly significant (F1,525¼7.7, P¼0.006): in A lines VO2swim
was higher in females than in males (Tukey–Kramer: t243¼2.6,
P¼0.04), whereas in C lines the difference was reversed, although
not significant (t681¼ –1.6, P¼0.36, Table. 1). The level of
VO2swim was affected by the Analyzer type (F1,994¼9.3,
P¼0.002), the Litter Number (LSM 6 SE: 1st litter 4.67 6 0.05, 2nd
litter 4.65 6 0.04, 3rd and 4th litter combined 4.75 6 0.04;
F2,1010¼4.0, P¼0.019), and number of pups in a litter
(slope 6 SE:0.02 6 0.01, t908¼1.8, P¼0.071). Likelihood ratio
test indicated that random effects of replicate Line (v2¼9.5,
P¼0.002) and Family (v2¼28.1, P¼0.000) contributed signifi-
cantly to the variation of VO2swim.
Results for the sub-sample of voles used in pharmacological tri-
als (N¼96) were similar to those for the whole dataset: selection-
trial VO2swim (adjusted for mean body mass) was higher in A lines
than in C lines (F1,6¼669, P<0.0001). The effect of Sex
(F1,81¼0.2, P¼0.7) was not significant, but the line Type Sex
interaction was significant (F1,80¼11.8, P¼0.001): in A lines fe-
males achieved a higher VO2swim than males did (Tukey–Kramer:
t79¼2.9, P¼0.022, Table 1), whereas in C lines the difference was
reversed, although not significant (t82¼2.0, P¼0.189, Table 1).
Cofactors had significant effect on the VO2swim (analyzer:
F1,78¼4.7, P¼0.033, the number of the pups in a litter: slope 6 SE:
0.02 6 0.01, t82¼2.1, P¼0.037).
Pre- and Post-trials
In the tests performed 15 weeks after the selection trial, voles from
A lines achieved significantly higher VO2swim than voles from C
lines (for mean body mass¼25 g: F1,17¼157, P<0.0001;
Figure 2A, C). The effect of Sex (F1,11¼0.7, P¼0.405) was not sig-
nificant, but the interaction term line Type Sex was significant
(F1,11¼10.6, P¼0.007). This was because in A lines females tended
to have higher VO2swim than males, whereas the trend was reversed
in C lines, although these differences were not significant (Tukey–
Kramer, A lines: t10¼1.7, P¼0.345; C lines: t13¼2.8,
P¼0.068). VO2swim did not differ between the pre- and post-trials
(F1,7¼4.5, P¼0.073; Figure 2A, C) and the interaction term line
TypeTrial was not significant, either (F1,7¼0.6, P¼0.481).
Running versus swimming
The analysis of covariance showed that the slopes of relationship be-
tween the rate of metabolism and body mass differed not only be-
tween the A and C lines (Table 2, discussed already above), but also
between VO2swim and VO2max (Exercise typeBody mass inter-
action: F1,70¼3.5, P¼0.65) and combinations of the selection and
Table 2. Partial results of the ANCOVA for the swim-induced (VO2swim) and forced-running (VO2max) aerobic metabolism, in which the
covariate was “body mass minus minimal observed body mass” (13 g in case of selection trial and 15 g in the other analyses; see
“Materials and Methods” for the rationale of the analysis)
Analysis line Type Body mass line TypeBody Mass
F value (Ddf, Ndf) Slopes 6 SE
[mLO2/(min g)]
t value (df) Difference in slopes 6 SE
[mLO2/(min g)]
t value (df)
P value P value P value
VO2swim selection trial (whole generation) 101 (1,47) 0.07 6 0.01 6.4 (394) 0.08 6 0.01 7.2 (434)
< 0.0001 < 0.0001 < 0.0001
VO2swim selection trial (voles used in
experimental trials)
85 (1,84) 0.04 6 0.01 4.9 (29) 0.10 6 0.01 8.4 (32)
< 0.0001 < 0.0001 < 0.0001
VO2swim pre- vs. post-trial (training effect) 5.4 (1,79) 0.01 6 0.02 0.4 (26) 0.12 6 0.03 4.9 (24)
0.022 0.662 < 0.0001
Pre-trial VO2swim vs. VO2max (voluntary vs.
forced performance)
10.7 (1,35) 0.10 6 0.02 6.4 (29) 0.02 6 0.02 1.1 (33)
0.002 < 0.0001 0.295
VO2swim 3 pharmacological trials (drug effect) 19.2 (1,20) 0.05 6 0.03 1.7 (20) 0.06 60.03 1.9 (16)
0.0003 0.097 0.071
The line Type effect provides a test of significance of the difference adjusted means of C and A lines at the minimum body mass, and the line TypeBody Mass
interaction describes the difference in regression slopes.
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exercise groups (second-order line TypeExercise typeBody
mass interaction: F1,70¼18.9, P<0.0001). This complex pattern
appeared because the slope for VO2swim in C lines was lower than
the 3 other slopes: for VO2max in C lines and both the VO2swim
and VO2max in A lines (Figure 3A). At the minimum observed body
mass (15 g), the effect of selection was significant (Table 2), but the
effect of Exercise type not (F1,44¼2.3, P¼0.14). The effect of
Exercise type was significant for body mass above 17 g (F1,36¼4.7,
P¼0.036), indicating a generally higher level of VO2max compared
with VO2swim, but the difference depended on both the body mass
and line Type (Figure 3). The analysis of covariance for the mean
body mass revealed not only significant main effects of line Type
(F1,6¼185, P<0.0001) and Exercise type (F1,6¼10.3, P<0.018),
but also significant interaction between the factors (F1,7¼68,
P<0.0001). The interaction appeared because in A lines the levels
of VO2max and VO2swim did not differ (Tukey–Kramer: t7¼0.6,
P¼0.92), whereas in C lines VO2max was much higher than
VO2swim (t7¼12.3, P<0.0001, Figure 3).
As in the analysis of VO2swim alone, the effect of Sex was not
significant (F1,89¼1.8, P¼0. 185), but line Type Sex interaction
was significant (F1,88¼13.8, P¼0.0004): in A lines females
achieved higher mass-adjusted VO2 (averaged across VO2swim and
VO2max) than males, but the difference was not significant (Tukey–
Kramer: t83¼1.8, P¼0.285), whereas in C lines the difference was
reversed and significant (t88¼3.3, P¼0.006).
The effect of the drug
During the 3 main trials voles from the A lines achieved a higher
VO2swim than those from C lines (at mean body mass¼25 g:
F1,6¼79, P<0.0001, Figure 2B, C). There was no differences be-
tween sexes (F1,7¼1.0, P¼0.341), and the interaction term line
Type Sex was not significant, either (F1,7¼4.4, P¼0.075). The
Drug had no effect on VO2swim (F2,146¼0.7, P¼0.475, Figure 2B,
C) and the interaction term line TypeDrug was not significant, ei-
ther (F2,145¼0.9, P¼0.394). Number of pups in a litter had signifi-
cant effect on the VO2swim (slope 6 SE: 0.09 6 0.03, t77¼2.8,
P¼0.006).
In addition, for the drug effect we analyzed also VO2swim calcu-
lated for 5-min maximum. The results were similar to those
described above (for 1-min-maximum VO2swim), with the signifi-
cant difference between A and C lines (F1,6¼80, P<0.0001), but
no effect of Drug (F2,13¼1.6, P¼0.239) or line TypeDrug inter-
action (F2,13¼0.6, P¼0.547).
Discussion
According to a general model of the evolution of complex adapta-
tions, natural selection in the first place operates on behavior.
However, because the range of behaviors available to an individual
is constrained by its organismal performance, the selection forces
subsequent changes in the morpho-physiological and biochemical
characteristics underlying the performance (Garland and Carter
1994). We reported that in generation 6 of the selection experiment
bank voles from both A and C lines achieved a higher 1-min maxi-
mum rate of oxygen consumption during forced running on a tread-
mill (VO2max) than during swimming (VO2swim; Sadowska 2008,
Koteja et al. 2009). Thus, apparently, the level of VO2swim was not
limited by the voles’ aerobic capacity at that time. However, in sub-
sequent generations the level of VO2swim continued to increase in
the A lines, and in generation 19 it approached that of VO2max
(Figure 3). On the other hand, in C lines VO2max was much higher
than VO2swim, but lower than VO2max in A line voles (Figure 3).
The results indicated that selection for high rate of voluntarily
achieved aerobic metabolism changed both the physiological abili-
ties (aerobic capacity) and behavioral trait (willingness to undertake
physical activity). It seems that evolution of the behavioral compo-
nent in our model has already pushed the vole’s performance in the
swimming test up to the limit imposed by physiological or bioche-
mical mechanisms. However, this latter conclusion should be treated
with caution, because VO2max was measured a few weeks after
VO2swim, whereas for a methodologically strong comparison both
Figure 2. The rate of aerobic metabolism achieved by bank voles from C-con-
trol (N¼48) and A-selected (N¼48) lines during repeated swimming trials
(VO2swim) that were preceded by injections (saline or bupropion). (A–B) The
relationship between VO2swim achieved in the pre- and post-trials (saline in-
jection; A) or in the 3 pharmacological trials (with injection of saline or bupro-
pion; B) and body mass. Dotted lines indicate the mean body mass (25 g) for
which the adjusted mean was calculated. (C) The adjusted least squares
mean (LSM) with 95% confidence limits (LSM [95% CL]) from 2 separate
mixed ANCOVA models (for pre- post-trials, and for the 3 in-between pharma-
cological trials).
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traits should be measured at the same age and in a randomized
order. At any rate, the observed pattern supports the general concept
of triggering the evolution of complex physiological adaptions by se-
lection acting on behavioral traits (e.g., Garland and Carter 1994,
Swallow et al. 2009).
In another experimental evolution model system, laboratory
mice selected for long-distance voluntary wheel running achieved a
higher VO2 during the voluntary running than control mice
(Rezende et al. 2005). All animals from that experiment achieved
higher VO2max during forced running, but there was no difference
in VO2max between selected and control mice (Rezende et al.
2005). Rezende et al. (2015) argued that selection for voluntary
wheel running resulted in the evolution of behavior (willingness to
undertake physical activity) independently of physical performance
abilities (aerobic capacity). However, laboratory mice were uninten-
tionally selected for over 400 generations toward decreased physical
activity (Garland et al. 2011), and this casts a doubt on the validity
of applying the inferences to wild animals and humans (Rezende
et al. 2005; Garland et al. 2011). Furthermore, wheel-running
behavior is difficult to interpret because it reflects not only general
activity, but also other behavioral traits such as addiction and anx-
iety-like behavior (Novak et al. 2012). Therefore, utilizing running
wheels in research concerning general physical activity requires care-
ful interpretation (Novak et al. 2012).
The study was designed to investigate if dopamine and noradren-
aline signaling regulate the motivation to be physically active and if
the motivation had changed due to selection for achieving high rate of
aerobic metabolism. We used a pharmacological manipulation ap-
proach that has been successfully applied in previous studies on corre-
lated response to artificial selection (Rhodes et al. 2001; Rhodes et al.
2003; Keeney et al. 2008; Keeney et al. 2012). As the experiment
required repeated trials on the same animals, in order to control for
putative effect of memory or training, we performed additional trials,
with only saline injections before and after the set of pharmacological
trials (pre- and post-trials). We found that the effect of training was
negligible, as there was no difference in the VO2swim achieved by the
voles in the pre- and post-trials (Figure 2A, C). Surprisingly, the dopa-
mine and noradrenaline reuptake inhibitor (bupropion) had no effect
on the VO2swim achieved by either the selected or control bank voles.
We hypothesized that even if bupropion did not influence the
VO2swim per se, it could change the swimming characteristics. For
example, the animals could achieve the same 1-min VO2swim after
bupropion and saline, but the drug could influence their motivation
to swim vigorously for a longer time, as the increase in brain dopa-
mine can delay fatigue (Davis and Bailey 1997) However, we did not
find a significant effect of the drug on VO2swim calculated for 5-min
periods, either. Thus, the results did not allow firm conclusions con-
cerning involvement of dopamine and noradrenaline in evolution of
increased aerobic exercise performance in the experimental evolution
model system.
Our model animals are not commonly used in pharmacological
studies and the data concerning pharmacology and pharmacokinetics
of different drugs administered to bank voles are scarce. This raises
the question whether the kind of drug, dose, and timing of administra-
tion before measuring the response variable were appropriate.
However, we chose the drug, dose, and timing that, according to the
literature, increases the level of physical activity in a variety of animal
species and humans (Cryan et al. 2001; Watson et al. 2005; Sidhpura
et al. 2007; Mori et al. 2013). For example, immobility time in forced
swimming test performed on mice decreased after intraperitoneal in-
jection (i.p.) of 30mg/kg bupropion (the drug was administered
30min before the test; Cryan et al. 2001). In another experiment,
locomotor activity of rats increased 20 min after 30 mg/kg bupropion
i.p., when compared with saline injection, and the effect lasted for 80
min (Sidhpura et al. 2007). In the same experiment, dopamine con-
centration in the rat brain (nucleus accumbens) increased after 30mg/
kg bupropion i.p., when compared with base values, achieved a peak
after 40 min and returned to basal values over next 20–40 min
(Sidhpura et al. 2007). Therefore, we expected that the drug should
affect the physical performance of the bank vole, too.
Finally, one could argue that behavior of the voles during the
swimming trial is determined by an ability to cope with the stressful
situation (cf. Kott et al. 2016). Inadequate coping with stress can, as
well as the lack of sufficient motivation, set the actual performance
well below the physiological or physical limits. Thus, in our selec-
tion model the selection could act on the ability to cope with stress
rather than on motivation—or on both of those behavioral mechan-
isms. Interestingly, female rats showed a stronger stress response to
the forced swimming test than males did (Dalla et al. 2008), and in
our experiment female voles from the unselected C lines achieved a
lower VO2swim compared with males, whereas the pattern was re-
versed in the A-selected lines (Table 1). Thus, it can be speculated
that the stress response indeed limited exercise performance of the
unselected voles and the limitation was stronger in females, but
Figure 3. The aerobic metabolism (VO2) achieved by control (N¼48) and selected (N¼ 48) bank voles during swimming (VO2swim) and forced running (VO2max).
(A) The relationship between VO2 and body mass. Dotted line indicate the mean body mass (25 g) used for calculating mass-adjusted VO2. (B) Adjusted least
squares mean with 95% confidence limits (LSM [95% CL]) from mixed ANCOVA models for selection (C lines vs. A lines) and exercise type (swim vs. forced run)
groups. Different lowercase letters (a, b, c) indicate significantly different groups (post hoc Tukey–Kramer comparisons).






/cz/article-abstract/62/3/307/2897734 by Jagiellonian U
niversity user on 08 April 2019
selection resulted in improved stress-coping, which revealed that fe-
males have actually a superior aerobic exercise performance. As the
selection experiment on bank voles is continued, further investiga-
tion of the putative neurophysiological mechanisms underlying the
evolution of high VO2swim is possible, and we will pursue the
opportunity both in the direction of stress-coping mechanisms (func-
tioning of hypothalamus–pituitary–adrenals axis) and the motiva-
tion mechanisms aspects (using different pharmacological substances
as well as direct measurements of monoamines in the brain).
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